Condensed Matter Physics
Condensed Matter Physics: a branch of physics that deals with the physical properties of condensed phases of matter, where particles adhere to each other. This includes the investigation of both crystalline solids in which the atoms are positioned on a repeating three-dimensional lattice, such as diamond, and amorphous materials in which atomic position is more irregular, like in glass. Condensed Matter physicists study how matter arises from a large number of interacting atoms and electrons, and what physical properties it has as a result of these interactions. The condensed matter field is considered one of the largest and most versatile sub-fields of study in physics, primarily due to the diversity of topics and phenomena that are available to study.
-
OCT 11, 2018 1:30 PM PDT
OCT 11, 2018 1:30 PM PDTAs the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...Speaker: Benjamin Anderson, MDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 12:00 PM PDT
OCT 11, 2018 12:00 PM PDTLung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...Speaker: Nicholas McGranahan, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 10:30 AM PDT
OCT 11, 2018 10:30 AM PDTTwo projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...Speaker: Kevin Williams, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 9:00 AM PDT
OCT 11, 2018 9:00 AM PDTThe oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...Speaker: Jason De Melo, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 7:30 AM PDT
OCT 11, 2018 7:30 AM PDTIn the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...Speaker: Krastan Blagoev, PhDPresented at: Cancer Research & Oncology 2018OCT 11, 2018 6:00 AM PDT
OCT 11, 2018 6:00 AM PDTPacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...Speaker: Jonas Korlach, PhDPresented at: Cancer Research & Oncology 2018OCT 10, 2018 12:00 PM PDT
OCT 10, 2018 12:00 PM PDTRNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...Speaker: Jonathan Shaffer, MBA, PhDPresented at: Cancer Research & Oncology 2018Sponsored By: QIAGENOCT 10, 2018 12:00 PM PDT
OCT 10, 2018 12:00 PM PDTTo date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...Speaker: Jerome Galon, PhDPresented at: Cancer Research & Oncology 2018OCT 10, 2018 9:00 AM PDT
OCT 10, 2018 9:00 AM PDTIn prior work, we have pursued how tumor reactive monoclonal antibody (mAb), together with activators of innate immune cells, like NK cells, can augment antibody dependent cell-mediated cytot...Speaker: Paul Sondel, MD, PhDPresented at: Cancer Research & Oncology 2018OCT 10, 2018 9:00 AM PDT
OCT 10, 2018 9:00 AM PDTHigh-throughput screening is widely useful in identifying genes and pathways that drive changes in cell behavior such as cell cycle regulation, metastasis, and drug resistance. Millipor...Speaker: Andrew Ravanelli, PhDPresented at: Cancer Research & Oncology 2018Sponsored By: MilliporeSigmaOCT 10, 2018 7:30 AM PDT
OCT 10, 2018 7:30 AM PDTMolecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...Speaker: Karin Rodland, PhDPresented at: Cancer Research & Oncology 2018OCT 10, 2018 6:00 AM PDT
OCT 10, 2018 6:00 AM PDTUnderstanding the immune repertoire is an important aspect of immuno-oncology research, which can be used to gather insights into the function and overall status of the immune system. We have...Speaker: Samuel Rulli, PhDPresented at: Cancer Research & Oncology 2018Sponsored By: QIAGEN
OCT 11, 2018
1:30 PM PDT
OCT 11, 2018
1:30 PM PDT
As the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...
Speaker:
Benjamin Anderson, MD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
12:00 PM PDT
OCT 11, 2018
12:00 PM PDT
Lung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...
Speaker:
Nicholas McGranahan, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
10:30 AM PDT
OCT 11, 2018
10:30 AM PDT
Two projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...
Speaker:
Kevin Williams, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
9:00 AM PDT
OCT 11, 2018
9:00 AM PDT
The oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...
Speaker:
Jason De Melo, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
7:30 AM PDT
OCT 11, 2018
7:30 AM PDT
In the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...
Speaker:
Krastan Blagoev, PhD
Presented at: Cancer Research & Oncology 2018
OCT 11, 2018
6:00 AM PDT
OCT 11, 2018
6:00 AM PDT
PacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...
Speaker:
Jonas Korlach, PhD
Presented at: Cancer Research & Oncology 2018
OCT 10, 2018
12:00 PM PDT
OCT 10, 2018
12:00 PM PDT
RNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...
Speaker:
Jonathan Shaffer, MBA, PhD
Presented at: Cancer Research & Oncology 2018Sponsored By: QIAGEN
OCT 10, 2018
12:00 PM PDT
OCT 10, 2018
12:00 PM PDT
To date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...
Speaker:
Jerome Galon, PhD
Presented at: Cancer Research & Oncology 2018
OCT 10, 2018
9:00 AM PDT
OCT 10, 2018
9:00 AM PDT
In prior work, we have pursued how tumor reactive monoclonal antibody (mAb), together with activators of innate immune cells, like NK cells, can augment antibody dependent cell-mediated cytot...
Speaker:
Paul Sondel, MD, PhD
Presented at: Cancer Research & Oncology 2018
OCT 10, 2018
9:00 AM PDT
OCT 10, 2018
9:00 AM PDT
High-throughput screening is widely useful in identifying genes and pathways that drive changes in cell behavior such as cell cycle regulation, metastasis, and drug resistance. Millipor...
Speaker:
Andrew Ravanelli, PhD
Presented at: Cancer Research & Oncology 2018Sponsored By: MilliporeSigma
OCT 10, 2018
7:30 AM PDT
OCT 10, 2018
7:30 AM PDT
Molecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...
Speaker:
Karin Rodland, PhD
Presented at: Cancer Research & Oncology 2018
OCT 10, 2018
6:00 AM PDT
OCT 10, 2018
6:00 AM PDT
Understanding the immune repertoire is an important aspect of immuno-oncology research, which can be used to gather insights into the function and overall status of the immune system. We have...
Speaker:
Samuel Rulli, PhD
Presented at: Cancer Research & Oncology 2018Sponsored By: QIAGEN
- Supercomputers
- Atomic Physics
- Materials Chemistry
- Algorithm
- Astrophysics
- ALS
- Scale-up
- Materials Science
- Atmospheric Sciences
- Atmospheric Chemistry
- Publishing
- Physical Cosmology
- Quantum Chemistry
- Space
- Experiment
- Nanolithography
- Optical Physics
- Molecular Techniques
- Plasma Physics
- Photonics
- Nanoparticles
- Nanofabrication
- Surface Chemistry
- Visualization
- Separations
- Compound Management
- Astrochemistry
- Bacteria
- Physics
- University
- Research
- Wellness
- Chemistry
- Computational Mechanics
- Applied Physics
- Computational Physics
- Nuclear Physics
- Physical Chemistry
- Nuclear Chemistry
- Theoretical Physics
- Technology
- Computational Chemistry
- Particle Physics
- T-Cells
- Computational Model
- Behavioral Research
- Behavior
- Theoretical Chemistry
- Mathematical Physics
- Industrial
- Digitalization
- Science